Chambers Rebecca
SEC CIK 1823563 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VCYT | VERACYTE, INC. | CFO | 166.0K | — | $2.82M | 37 | 2021-07-19 | 2026-09-04 |
Most active insiders at VCYT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stapley Marc | CEO, Dir | — | $8.92M |
| 2 | JONES EVAN/ FA | Dir | — | $2.00M |
| 3 | Chambers Rebecca | CFO | — | $1.91M |
| 4 | McGuire Annie | SVP, GC | — | $1.80M |
| 5 | Wygant Jonathan | VP, CAO | — | $1.54M |
| 6 | EASTHAM KARIN | Dir | — | $1.49M |
| 7 | Febbo Phillip G. | Chief Scientific, Med Off | — | $1.35M |
| 8 | Leite John | Gbl Chief Commercial Off | — | $1.34M |
| 9 | EPSTEIN ROBERT S | Dir | — | $1.19M |
| 10 | Holstein Jens | Dir | — | $628.3K |
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-04 19:54 | 2026-09-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $44.88 | -3,603 | 169.7K | -2% | -$161.7K |
| MT | 2026-09-04 19:54 | 2026-09-04 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | S - Sale | $43.10 | -3,652 | 166.0K | -2% | -$157.4K |
| T | 2026-06-04 21:38 | 2026-06-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $47.80 | -3,693 | 176.8K | -2% | -$176.5K |
| MT | 2026-06-04 21:38 | 2026-06-04 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | S - Sale | $49.73 | -3,561 | 173.3K | -2% | -$177.1K |
| M | 2026-03-10 | 2026-03-06 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | A - Grant | $0.00 | +49.3K | 180.5K | +38% | $0 |
| M | 2026-03-06 | 2026-03-04 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | S - Sale | $36.14 | -18.3K | 145.1K | -11% | -$662.9K |
| 2026-03-04 | 2026-03-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $36.01 | -7,234 | 149.5K | -5% | -$260.5K | |
| 2026-03-02 | 2026-02-26 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | A - Grant | $0.00 | +59.3K | 168.8K | +54% | $0 | |
| 2026-03-02 | 2026-02-26 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $38.75 | -12.0K | 156.8K | -7% | -$466.9K | |
| M | 2025-12-04 | 2025-12-04 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | S - Sale | $46.84 | -13.3K | 114.2K | -10% | -$621.9K |
| 2025-12-04 | 2025-12-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $46.16 | -3,384 | 122.8K | -3% | -$156.2K | |
| 2025-11-07 | 2025-11-05 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | S - Sale | $41.00 | -7,000 | 126.2K | -5% | -$287.0K | |
| 2025-09-04 | 2025-09-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $30.11 | -5,371 | 133.2K | -4% | -$161.7K | |
| 2025-06-04 | 2025-06-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $26.74 | -5,370 | 138.5K | -4% | -$143.6K | |
| 2025-03-10 | 2025-03-06 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | A - Grant | $0.00 | +30.2K | 143.9K | +27% | $0 | |
| M | 2025-03-03 | 2025-02-27+ | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $34.28 | -23.0K | 124.8K | -16% | -$787.9K |
| 2025-03-03 | 2025-02-27 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | A - Grant | $0.00 | +23.2K | 136.7K | +20% | $0 | |
| 2025-02-05 | 2025-02-03 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | S - Sale | $43.85 | -527 | 113.5K | -0.5% | -$23.1K | |
| 2024-12-04 | 2024-12-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $44.12 | -3,464 | 121.0K | -3% | -$152.8K | |
| 2024-12-04 | 2024-12-03 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | S - Sale | $43.23 | -7,000 | 114.0K | -6% | -$302.6K | |
| 2024-11-14 | 2024-11-12 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | S - Sale | $38.34 | -15.3K | 124.5K | -11% | -$585.6K | |
| 2024-09-04 | 2024-09-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $31.55 | -3,464 | 139.8K | -2% | -$109.3K | |
| 2024-06-04 | 2024-06-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $20.75 | -3,462 | 143.2K | -2% | -$71.8K | |
| 2024-03-19 | 2024-03-15 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | A - Grant | $0.00 | +4,318 | 148.9K | +3% | $0 | |
| 2024-03-19 | 2024-03-15 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $21.10 | -2,189 | 146.7K | -1% | -$46.2K | |
| 2024-03-08 | 2024-03-06 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | A - Grant | $0.00 | +59.9K | 144.6K | +71% | $0 | |
| 2024-03-05 | 2024-03-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $24.00 | -6,112 | 84.7K | -7% | -$146.7K | |
| 2023-12-05 | 2023-12-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $26.54 | -1,800 | 90.8K | -2% | -$47.8K | |
| 2023-09-06 | 2023-09-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $26.70 | -3,652 | 92.6K | -4% | -$97.5K | |
| 2023-06-06 | 2023-06-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $26.72 | -1,183 | 95.8K | -1% | -$31.6K | |
| D | 2023-03-09 | 2023-03-06 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | A - Grant | $0.00 | +26.0K | 96.9K | +37% | $0 |
| 2023-03-03 | 2023-03-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $24.10 | -2,726 | 70.9K | -4% | -$65.7K | |
| 2022-12-06 | 2022-12-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $29.14 | -735 | 73.0K | -1.0% | -$21.4K | |
| 2022-09-07 | 2022-09-02 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | F - Tax | $19.18 | -3,023 | 73.7K | -4% | -$58.0K | |
| D | 2022-08-09 | 2022-08-05 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | A - Grant | $0.00 | +21.4K | 76.8K | +39% | $0 |
| D | 2022-03-07 | 2022-03-03 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | A - Grant | $0.00 | +20.7K | 54.7K | +61% | $0 |
| D | 2021-07-20 | 2021-07-19 | VCYT | VERACYTE, INC. | Chambers Rebecca | CFO | A - Grant | $0.00 | +34.0K | 34.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations